Literature DB >> 7523413

Export of protein from the endoplasmic reticulum is regulated by a diacylglycerol/phorbol ester binding protein.

M Fabbri1, S Bannykh, W E Balch.   

Abstract

The export of vesicular stomatitis virus glycoprotein (VSV-G) from the endoplasmic reticulum (ER) involves sorting and concentration, and has been proposed to require the function of heterotrimeric G proteins. To begin to identify the basic elements of a potential signaling pathway involved in vesicle assembly, we have examined whether protein kinase C (PKC) is required for ER to Golgi transport. Calphostin C, a specific inhibitor of the highly conserved cysteine-rich C6H2 motif present in the regulatory domain of PKC was found to be a potent inhibitor of export of VSV-G and vesicle budding from the ER in vivo and in vitro (IC50 approximately 60 nM). In contrast, the diacylglycerol analog phorbol 12-myristate 13-acetate, which activates PKC, enhanced the migration of VSV-G from the ER to pre-Golgi intermediates. Neither reagent had detectable effects on the oligomerization of VSV-G prior to export nor perturbed transport of protein between compartments of the Golgi stack. In contrast to the striking effects of calphostin C, reagents that inhibit the function of the catalytic domain of PKC (including the general kinase inhibitor staurosporine, as well as the more specific inhibitors H-7, H-8, pseudosubstrate inhibitor, or chelerythrine) did not inhibit export from the ER. Export was also insensitive to down-regulation of various PKC isoforms. These results suggest that a novel protein containing the conserved C6H2 motif may serve as a potential link in a signaling pathway regulating vesicle budding from the ER.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523413

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  A Rab2 mutant with impaired GTPase activity stimulates vesicle formation from pre-Golgi intermediates.

Authors:  E J Tisdale
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

Review 2.  Myelin biogenesis: vesicle transport in oligodendrocytes.

Authors:  J N Larocca; A G Rodriguez-Gabin
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

3.  The lysophospholipid acyltransferase antagonist CI-976 inhibits a late step in COPII vesicle budding.

Authors:  William J Brown; Helen Plutner; Daniel Drecktrah; Bret L Judson; William E Balch
Journal:  Traffic       Date:  2008-03-04       Impact factor: 6.215

4.  Thapsigargin-induced transport of cholera toxin to the endoplasmic reticulum.

Authors:  K Sandvig; O Garred; B van Deurs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-29       Impact factor: 11.205

5.  Protein kinase C bound to the Golgi apparatus supports the formation of constitutive transport vesicles.

Authors:  P Westermann; M Knoblich; O Maier; C Lindschau; H Haller
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

Review 6.  Phorbol esters and neurotransmitter release: more than just protein kinase C?

Authors:  Eugene M Silinsky; Timothy J Searl
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

7.  Zn2+ depletion blocks endosome fusion.

Authors:  A Aballay; M N Sarrouf; M I Colombo; P D Stahl; L S Mayorga
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

8.  Killing of cancer cells by the photoactivatable protein kinase C inhibitor, calphostin C, involves induction of endoplasmic reticulum stress.

Authors:  Aparna Kaul; William A Maltese
Journal:  Neoplasia       Date:  2009-09       Impact factor: 5.715

9.  Identification of the putative mammalian orthologue of Sec31P, a component of the COPII coat.

Authors:  C A Shugrue; E R Kolen; H Peters; A Czernik; C Kaiser; L Matovcik; A L Hubbard; F Gorelick
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

Review 10.  The physiology of membrane transport and endomembrane-based signalling.

Authors:  Michele Sallese; Teodoro Pulvirenti; Alberto Luini
Journal:  EMBO J       Date:  2006-06-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.